OXFORD, England, July 16, 2014 /PRNewswire/ --
Elsevier, world-leading provider of scientific, technical and
medical information products and services, is pleased to announce
the launch of a new open access journal: Bone Reports.
As sister publication to the highly reputable journal
Bone, Bone Reports will serve as an interdisciplinary
forum for the rapid publication of research articles and case
reports across basic, translational and clinical aspects of bone
and mineral metabolism. The journal welcomes studies replicating or
failing to replicate previous studies.
Editor-in-Chief for Bone Reports, Professor Peter R. Ebeling, Monash University, and also
Senior Editor for sister journal Bone, commented, "I am
excited to serve as Editor-in-Chief of Bone Reports, which
fulfills a critical and current need to enhance research by
publishing reproducibility studies and null findings."
"I am delighted to partner with Professor Ebeling," said
Editor-in-Chief of Bone, Professor Sundeep Khosla, Mayo Clinic, explaining that,
"with the launch of Bone Reports authors now have a new
option to publish solid science related to bone metabolism. I
believe the two journals will complement each other very well and
expand the scope of content we can provide to our readers."
For more information or to submit an article, go to:
http://www.journals.elsevier.com/bone-reports/
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since
2005. Today, researchers can choose to publish open access in over
1,600 established peer-reviewed journals as well as over 100 full
open access journals and these numbers will continue to grow
rapidly. All of Elsevier's open access publications have been peer
reviewed, ensuring that the broader community not only reads the
latest research but that it is factual, original and of the highest
quality and ethical standards. For more information about
Elsevier's open access program, visit
http://www.elsevier.com/openaccess.
About Elsevier
Elsevier is a world-leading provider of information solutions that
enhance the performance of science, health, and technology
professionals, empowering them to make better decisions, deliver
better care, and sometimes make groundbreaking discoveries that
advance the boundaries of knowledge and human progress. Elsevier
provides web-based, digital solutions - among them
ScienceDirect, Scopus, Elsevier Research Intelligence and
ClinicalKey - and publishes nearly 2,200 journals, including The
Lancet and Cell, and over 25,000 book titles, including
a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading
provider of professional information solutions in the Science,
Medical, Legal and Risk and Business sectors, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols
are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).
Media contact
Joanna Cipolla
Elsevier
+44(0)18-65-84-34-77
j.cipolla@elsevier.com
